NHS :: Success and progress in A&E, UK
Over the last year the NHS has continued to deliver the fastest ever access to A&E treatment, figures released from the UK Department of Health show.
Treatment
HIV :: Abbott’s HIV-1 Viral Load Test Approved by FDA for Use on New m2000 Molecular Diagnostics Instrument
Abbott (NYSE: ABT) and Celera (NYSE:CRA), an Applera Corporation business, announced that Abbott has received U.S. Food and Drug Administration (FDA) approval to market the Abbott RealTime HIV-1 viral load test for use on the company?s m2000? automated instrument system.
Hepatitis C :: Schering-Plough presenting Hepatitis C at Digestive Disease Week 2007 Annual Meeting
A total of 20 oral and poster presentations on clinical studies with Schering-Plough’s hepatitis products, including PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy for chronic hepatitis C virus (HCV) infection, as well as boceprevir (SCH 503034), the company’s investigational oral HCV protease inhibitor currently in Phase II clinical development, will be presented by leading researchers at the 38th annual Digestive Disease Week (DDW) meeting to be held at the Washington Convention Center in Washington, D.C., May 20-23.
Back Pain :: New treatment offers relief from chronic back pain
Chronic back pain is a condition that affects a significant part of the population, with patients falling into three major groups; those with herniated discs, spinal stenosis (a nerve affecting narrowing of the spinal cord), and complications from failed back surgery.
COPD :: Neglected global epidemic of chronic obstructive lung disease
Chronic obstructive pulmonary disease (COPD) is a major and increasing global health epidemic that has received insufficient attention from the health-care profession, governments, and the pharmaceutical industry, argues Professor Peter Barnes, one of the world’s leading experts on lung disease.
HIV :: $9.7 Million Gates Grant for Pediatric AIDS Vaccine Research
The Elizabeth Glaser Pediatric AIDS Foundation has received a five-year, $9.7-million grant from the Bill & Melinda Gates Foundation to develop and test candidate vaccines to prevent HIV infection in children.
Pregnancy :: Aspirin reduces pregnancy complication risk, pre-eclampsia
Women who receive aspirin during pregnancy are at lower risk of pre-eclampsia a pregnancy complication, revealed by researchers from Australia and the UK.
Hair Loss :: Follica developing breakthrough discovery to treat hair loss
Technology licensed by Follica Inc. from the University of Pennsylvania School of Medicine has been used to generate completely new hair follicles for the first time in normal adult mammals. The paper describing the experiment was published in the May 17th issue of the scientific journal Nature.
Healthcare :: 25,000 needless deaths each year due to failure to tackle blood clots in hospital
Up to 25,000 people may die needlessly each year due to the failure to prevent blood clots known as venous thromboembolisms (VTE) in UK hospitals, say experts in this week’s BMJ.
Depression :: Minorities prefer counseling to drugs for treating depression
Some ethnic minorities could be twice as likely as white and Native American people to prefer counseling and prayer to medication for treating depression, according to a national Internet survey.